Literature DB >> 10322866

[Effect of tongxinluo capsule on experimental myocardial ischemia, arrhythmia and hyperlipidemia].

J X Liu1, X H Shang, G Wang.   

Abstract

OBJECTIVE: To study the effects of Tongxinluo capsule (TXLC) on experimental myocardial ischemia and infarction, arrhythmia and hyperlipidemia.
METHODS: Using the methods of epicardial mapping and NBT-ink double staining and the ratio of tissue in myocardial infarction in which the anterior coronary artery was ligated in anesthetized dogs, acute myocardial ischemia was induced with pituitrin and hyperlipidemia was induced with feeding high lipid diet in rats, arrhythmia was induced with chloroform in mice.
RESULTS: The TXLC reduced significantly the myocardial ischemic limits, degree and the myocardial infarction area, inhibited obviously the ocurrence of arrhythmia and reduced the level of hyperlipidemia.
CONCLUSION: The TXLC could improve significantly the myocardial ischemia mycardial infarction and prevent obviously the ocurrence of arrhythmia and hyperlipidemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10322866

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  5 in total

1.  Serum low-density lipoprotein and heart rate related to the effectiveness in the treatment of angina pectoris with two similar Chinese medicine herbal formulae.

Authors:  Shi-yan Yan; Chen Yao; Xiao-rong Ding; Miao Jiang; Ai-ping Lu
Journal:  Chin J Integr Med       Date:  2011-12-03       Impact factor: 1.978

Review 2.  Herbal medicine: beneficial effects, side effects, and promising new research in the treatment of arrhythmias.

Authors:  C William Stout; Jonathan Weinstock; Munther K Homoud; Paul J Wang; N A Mark Estes; Mark S Link
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

3.  Effects of Corocalm (shuguan capsule) on acute myocardial ischemia in anesthetized dogs.

Authors:  Jian-xun Liu; Xin-zhi Li; Wei-hong Cong; Jian-hua Fu; Xiao-hong Shang
Journal:  Chin J Integr Med       Date:  2007-09       Impact factor: 1.978

4.  Tongxinluo Regulates Expression of Tight Junction Proteins and Alleviates Endothelial Cell Monolayer Hyperpermeability via ERK-1/2 Signaling Pathway in Oxidized Low-Density Lipoprotein-Induced Human Umbilical Vein Endothelial Cells.

Authors:  Chengcheng Chang; Hongli Liu; Cong Wei; Liping Chang; Junqing Liang; Hongying Bei; Hongrong Li; Shen Liu; Yiling Wu
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-19       Impact factor: 2.629

5.  Chinese patent medicine tongxinluo capsule for hypertension: a systematic review of randomised controlled trials.

Authors:  Jie Wang; Xingjiang Xiong; Wei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-17       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.